Cas:144964-17-0 1,1,1-Trimethyl-N-phenethyl-N-(trimethylsilyl)silanamine manufacturer & supplier

Chemical Name:1,1,1-Trimethyl-N-phenethyl-N-(trimethylsilyl)silanamine

CAS.NO:144964-17-0

Synonyms:Benzyl-bis-trimethylsilanylmethylamine;N,N-Bis[(trimethylsilyl)methyl]benzenemethanamine

Molecular Formula:C₁₄H₂₇NSi₂

Molecular Weight:265.54200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:264.544ºC at 760 mmHg

Density:0.883g/cm3

Index of Refraction:1.477

PSA:3.24000

Exact Mass:265.16800

LogP:4.20090

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Benzyl-bis-trimethylsilanylmethylamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N,N-Bis[(trimethylsilyl)methyl]benzenemethanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N,N-Bis[(trimethylsilyl)methyl]benzenemethanamine Use and application,Benzyl-bis-trimethylsilanylmethylamine technical grade,usp/ep/jp grade.

Related News: This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.? 1,1,1-Trimethyl-N-phenethyl-N-(trimethylsilyl)silanamine manufacturer The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry. 1,1,1-Trimethyl-N-phenethyl-N-(trimethylsilyl)silanamine supplier The upstream industry for the R & D, production and sales of pharmaceutical intermediates is the basic chemical raw material industry, and the downstream industry is the chemical bulk drug and chemical pharmaceutical preparation industry. 1,1,1-Trimethyl-N-phenethyl-N-(trimethylsilyl)silanamine vendor At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 1,1,1-Trimethyl-N-phenethyl-N-(trimethylsilyl)silanamine factory Thank you for being open” about the diagnosis, NBC’s chief foreign affairs correspondent and anchor Andrea Mitchell wrote to Amanpour on Twitter. “It is so important and typical of how strong and brave you’ve always been. Courage and honesty is your trademark. You will beat this too.